Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data

Trifluridine/tipiracil increases overall survival (OS) in patients with refractory, metastatic colorectal cancer (mCRC). A post hoc exploratory analysis of the RECOURSE randomized clinical trial (RCT) established two categories, a good prognosis corresponding to subjects having a low tumor burden an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Fernández Montes, Ana, Carmona-Bayonas, Alberto, Jimenez-Fonseca, Paula, Vázquez Rivera, Francisca, Martinez Lago, Nieves, Covela Rúa, Marta, Cousillas Castiñeiras, Antía, Gonzalez Villarroel, Paula, De la Cámara Gómez, Juan, Méndez, José Carlos Méndez, Carriles Fernández, Carmen, Sanchez Cánovas, Manuel, Garcia García, Teresa
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8275736/
https://ncbi.nlm.nih.gov/pubmed/34253805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-93732-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars